Showing results (31-40 of 44) with videos related to
Sort By:
Pageof 5
Journal of Applied Physiology (Bethesda, Md. : 1985)|April 26, 2014
Total body skeletal muscle mass: estimation by creatine (methyl-d3) dilution in humansRichard V Clark, Ann C Walker, Robin L O'Connor-Semmes, et al.Journal of Applied Physiology (Bethesda, Md. : 1985)|March 17, 2012
Total-body creatine pool size and skeletal muscle mass determination by creatine-(methyl-D3) dilution in ratsStephen A Stimpson, Scott M Turner, Lisa G Clifton, et al.American Journal of Physiology. Endocrinology and Metabolism|December 31, 2015
Proteome-wide muscle protein fractional synthesis rates predict muscle mass gain in response to a selective androgen receptor modulator in ratsMahalakshmi Shankaran, Todd W Shearer, Stephen A Stimpson, et al.The Journal of Clinical Investigation|November 4, 2009
Mfge8 diminishes the severity of tissue fibrosis in mice by binding and targeting collagen for uptake by macrophagesKamran Atabai, Sina Jame, Nabil Azhar, et al.Annals of the American Thoracic Society|November 5, 2024
Bexotegrast Shows Dose-Dependent Integrin αvβ6 Receptor Occupancy in Lungs of Participants with Idiopathic Pulmonary Fibrosis: A Phase 2, Open-Label Clinical TrialJoshua J Mooney, Susan Jacobs, Éric A Lefebvre, et al.Journal of Lipid Research|May 8, 2013
In vivo tissue cholesterol efflux is reduced in carriers of a mutation in APOA1Adriaan G Holleboom, Lily Jakulj, Remco Franssen, et al.Hepatology (Baltimore, Md.)|October 6, 2016
Identifying nonalcoholic fatty liver disease patients with active fibrosis by measuring extracellular matrix remodeling rates in tissue and bloodMartin L Decaris, Kelvin W Li, Claire L Emson, et al.JCI Insight|February 1, 2017
Leukemia cell proliferation and death in chronic lymphocytic leukemia patients on therapy with the BTK inhibitor ibrutinibJan A Burger, Kelvin W Li, Michael J Keating, et al.Journal of Medicinal Chemistry|November 26, 2014
Decreasing the rate of metabolic ketone reduction in the discovery of a clinical acetyl-CoA carboxylase inhibitor for the treatment of diabetesDavid A Griffith, Daniel W Kung, William P Esler, et al.Therapeutic Advances in Respiratory Disease|November 8, 2024
Bexotegrast in people with idiopathic pulmonary fibrosis (IPF): a plain language summary of publication of the INTEGRIS-IPF studyLisa Lancaster, Vincent Cottin, Murali Ramaswamy, et al.Pageof 5